Table 5.

Multivariate analysis for variables associated with progression^a, n = 100

	Progressed	Did not progress	P value	aOR (95% CI)	p value
Age in years, median (IQR)	56 (52–64)	48 (31–60)	0.018	1.04 (0.99–1.08)	0.065
Chemotherapy < 30 days	14 (29.2)	34 (70.8)	0.054	1.93 (0.62–5.97)	0.255
Rituximab use	16 (32)	34 (68)	0.007	2.65 (0.70–10.02)	0.151
Remdesivir use	8 (30.8)	18 (69.2)	0.155	0.83 (0.24–2.89)	0.767
Hospital admission for non-COVID causes	7 (41.2)	10 (58.8)	0.025	4.77 (1.09–20.87)	0.038

^aAsymptomatic and critical patients were excluded